Indigo naturalis as a promising novel treatment for type 2 autoimmune pancreatitis

Ken Kamata; Masatoshi Kudo; Tomohiro Watanabe

doi:10.1016/j.pan.2024.03.011

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

Identification of serum IFN-α and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease

Kosuke Minaga, Tomohiro Watanabe, Akane Hara, Ken Kamata, Shunsuke Omoto, Atsushi Nakai, Yasuo Otsuka, Ikue Sekai, Tomoe Yoshikawa, Kentaro Yamao, Mamoru Takenaka, Yasutaka Chiba, Masatoshi Kudo

Article2021

Plasmacytoid Dendritic Cells as a New Therapeutic Target for Autoimmune Pancreatitis and IgG4-Related Disease

Kosuke Minaga, Tomohiro Watanabe, Akane Hara, Tomoe Yoshikawa, Ken Kamata, Masatoshi Kudo

Article2021

A unique profile of serum cytokines in type 1 autoimmune pancreatitis and chronic rhinosinusitis

Tomoe Yoshikawa, Kosuke Minaga, Akane Hara, Ikue Sekai, Yasuo Otsuka, Ryutaro Takada, Ken Kamata, Tomohiro Watanabe, Masatoshi Kudo

Article2017

The role of endoscopic ultrasonography in diagnosis and treatment of autoimmune pancreatitis

Shunusuke Omoto, Mamoru Takenaka, Masatoshi Kudo, Masayuki Kitano

Article2020

Gut microbiome alterations in type 1 autoimmune pancreatitis after induction of remission by prednisolone

Ken Kamata, Tomohiro Watanabe, Kosuke Minaga, Akane Hara, Ikue Sekai, Yasuo Otsuka, Tomoe Yoshikawa, A.M. Park, Masatoshi Kudo